Paul S, Biswas S, Milner J, Tomsick P, Pickrell A
Traffic. 2025; 26(1-3):e70000.
PMID: 40047067
PMC: 11883510.
DOI: 10.1111/tra.70000.
Dickerson B, Atri A, Clevenger C, Karlawish J, Knopman D, Lin P
Alzheimers Dement. 2024; 21(1):e14337.
PMID: 39713957
PMC: 11772716.
DOI: 10.1002/alz.14337.
Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C
Brain. 2024; 148(2):408-415.
PMID: 39679606
PMC: 11788209.
DOI: 10.1093/brain/awae368.
McKenna M, Kleinerova J, Power A, Garcia-Gallardo A, Tan E, Bede P
Biology (Basel). 2024; 13(11).
PMID: 39596864
PMC: 11592215.
DOI: 10.3390/biology13110909.
Bampton A, McHutchison C, Talbot K, Benatar M, Thompson A, Turner M
Brain Behav. 2024; 14(11):e70115.
PMID: 39501538
PMC: 11538089.
DOI: 10.1002/brb3.70115.
Clinical, Cortical, Subcortical, and White Matter Features of Right Temporal Variant FTD.
Kleinerova J, McKenna M, Finnegan M, Tacheva A, Garcia-Gallardo A, Mohammed R
Brain Sci. 2024; 14(8).
PMID: 39199498
PMC: 11352857.
DOI: 10.3390/brainsci14080806.
Genetic Landscape of Amyotrophic Lateral Sclerosis in Czech Patients.
Baumgartner D, Musova Z, Zidkova J, Hedvicakova P, Vlckova E, Joppekova L
J Neuromuscul Dis. 2024; 11(5):1035-1048.
PMID: 39058450
PMC: 11380243.
DOI: 10.3233/JND-230236.
Unraveling the complexity of human brain: Structure, function in healthy and disease states.
Sultana O, Bandaru M, Islam M, Reddy P
Ageing Res Rev. 2024; 100:102414.
PMID: 39002647
PMC: 11384519.
DOI: 10.1016/j.arr.2024.102414.
Identification of a pathogenic mutation in in patients with amyotrophic lateral sclerosis.
Dols-Icardo O, Carbayo A, Jerico I, Blasco-Martinez O, Alvarez-Sanchez E, Lopez Perez M
J Neurol Neurosurg Psychiatry. 2024; 96(2):132-139.
PMID: 38960585
PMC: 11877019.
DOI: 10.1136/jnnp-2024-333834.
Shotgun Proteomics Links Proteoglycan-4 Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis.
Vilardo B, De Marchi F, Raineri D, Manfredi M, De Giorgis V, Bebeti A
Biomolecules. 2024; 14(6).
PMID: 38927130
PMC: 11202157.
DOI: 10.3390/biom14060727.
Repeated cognitive assessments show stable function over time in patients with ALS.
Oijerstedt L, Foucher J, Lovik A, Yazdani S, Juto A, Klappe U
J Neurol. 2024; 271(8):5267-5274.
PMID: 38853167
PMC: 11319384.
DOI: 10.1007/s00415-024-12479-x.
Update on recent advances in amyotrophic lateral sclerosis.
Riva N, Domi T, Pozzi L, Lunetta C, Schito P, Spinelli E
J Neurol. 2024; 271(7):4693-4723.
PMID: 38802624
PMC: 11233360.
DOI: 10.1007/s00415-024-12435-9.
Financial and numerical abilities: patterns of dissociation in neurological and psychiatric diseases.
Burgio F, Danesin L, Wennberg A, Tonini E, Galetto V, Sivieri S
Neurol Sci. 2024; 45(10):4779-4787.
PMID: 38780855
DOI: 10.1007/s10072-024-07610-9.
Relationship between neuroimaging and cognition in frontotemporal dementia: An FDG-PET and structural MRI study.
Cayir S, Volpi T, Toyonaga T, Gallezot J, Yang Y, Sadabad F
J Neuroimaging. 2024; 34(5):627-634.
PMID: 38676301
PMC: 11511789.
DOI: 10.1111/jon.13206.
Unraveling the Heterogeneity of ALS-A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials.
Tzeplaeff L, Jurs A, Wohnrade C, Demleitner A
Cells. 2024; 13(5.
PMID: 38474416
PMC: 10930688.
DOI: 10.3390/cells13050452.
Analysis of repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS).
Kekenadze M, Rocca C, Turchetti V, Nagy S, Kvirkvelia N, Vashadze S
F1000Res. 2024; 12:1113.
PMID: 38464738
PMC: 10924727.
DOI: 10.12688/f1000research.138436.1.
Quality of life, cognitive and behavioural impairment in people with motor neuron disease: a systematic review.
Radakovic R, Radakovic C, Abrahams S, Simmons Z, Carroll A
Qual Life Res. 2024; 33(6):1469-1480.
PMID: 38345764
PMC: 11116232.
DOI: 10.1007/s11136-024-03611-5.
Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia.
Malerba F, Florio R, Arisi I, Zecca C, DellAbate M, Logroscino G
Front Aging Neurosci. 2024; 15:1298307.
PMID: 38332808
PMC: 10850263.
DOI: 10.3389/fnagi.2023.1298307.
Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum.
Carbayo A, Borrego-Ecija S, Turon-Sans J, Cortes-Vicente E, Molina-Porcel L, Gascon-Bayarri J
Brain. 2024; 147(7):2357-2367.
PMID: 38227807
PMC: 11224598.
DOI: 10.1093/brain/awae011.
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
Shen T, Vogel J, Duda J, Phillips J, Cook P, Gee J
Transl Neurodegener. 2023; 12(1):57.
PMID: 38062485
PMC: 10701950.
DOI: 10.1186/s40035-023-00389-3.